This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
Save the dateMarch 17–19, 2025 | Milan, Italy

Carlos Buesa
CEO at Oryzon Genomics


D. Carlos Buesa holds a PhD in Biology from the University of Barcelona, was a postdoctoral researcher with a European Union grant and Senior Researcher at the Flemish Institute of Biotechnology (VIB). He has completed several advanced programs in finance, business development, international trade, and negotiation. In addition, in 2005 he completed Senior Management Studies (PADE) at IESE Business School.

He has obtained the IC-A Diploma in Good Corporate Governance from the Instituto de Consejeros Administradores de España.

In recent years he has been a director of various biotechnology companies and is a founding partner of MENDELION LIFESCIENCES, S.L. He was the first President of the Catalan Association of Biocompanies (CataloniaBio) and has been a member and Vice-President representing ORYZON on the Board of Directors of the Spanish Association of Biocompanies (ASEBIO), in several mandates and is currently First Vice-President.

Finally, he has been a member of the Board of Directors of INVEREADY SEED CAPITAL and INVEREADY BIOTECH since 7 September 2008 and 10 October 2012, respectively, until June 2021.

Agenda Sessions

  • Business development round-up “have we got a deal? - key takeaways from this week's partnering meetings”